SecBot SecBot
6-K ·Filed May 18, 2026

CCM

Concord Medical Services Holdings Ltd
NEUTRAL
Impact 4/10
Horizonweeks Processed6mo ago SEC0001104659-26-062981
Notable filing: 6-K
Actionable Insight • Neutral

Monitor for management's determination on Concord Healthcare's consolidation status, as deconsolidation could significantly alter CCM's reported revenue and asset base. The stock may see volatility on any announcement regarding this review.

DirectionNeutral
Confidencemedium
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$5.17
T+0 close · May 18, 2026 · via day close
Latest settled
−7.35%
T+60 · $4.79
Vs SPY
−12.20%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 18 $5.17entry
  2. T+1 · 6mo ago −4.45%α −3.80% · $4.94
  3. T+5 · 6mo ago −5.42%α −7.03% · $4.89
  4. T+20 · 5mo ago −9.09%α −10.67% · $4.70
  5. T+60 · 3mo ago −7.35%α −12.20% · $4.79

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Concord Medical Services Holdings Ltd filed a 6-K reporting that Mr. Liang Chang resigned as an executive director of its subsidiary, Concord Healthcare Group Co., Ltd., effective May 11, 2026, and Ms. Li Jiang was elected as an employee director on the same day. Management is reviewing whether Concord Healthcare still qualifies as a consolidated subsidiary under applicable accounting standards, creating uncertainty about the company's financial structure.

Key Facts

  • Mr. Liang Chang resigned as executive director of Concord Healthcare effective May 11, 2026.
  • Ms. Li Jiang was elected as an employee director of Concord Healthcare on May 11, 2026.
  • Management is reviewing whether Concord Healthcare remains a consolidated subsidiary of the company.
  • No financial figures or material financial impact were disclosed in the filing.

Financial Impact

No financial impact quantified; potential deconsolidation of Concord Healthcare could materially affect reported financials, but outcome is uncertain.

revenuenet incometotal assetsconsolidation status

Risk Factors

  • Deconsolidation of Concord Healthcare could materially reduce reported revenue and assets.
  • Uncertainty around the review timeline and outcome may weigh on investor sentiment.
  • The filing provides no financial details, limiting near-term trading catalysts.

Market Snapshot

Exchange
NYSE
Sector
Services-Offices & Clinics of Doctors of Medicine
Analyst Consensus
0% bullish (8 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001104659-26-062981
Document: 0001104659-26-062981-index-headers.html0001104659-26-062981
Document: 0001104659-26-062981-index.html0001104659-26-062981
Document: 0001104659-26-062981.txt0001104659-26-062981

Track record

3 reports on CCM

Performance horizon
Filters
  1. Jul 2, 202619w ago 6-K Neutral 3/10 Entry $4.39 to $4.65 Now $3.59 −18.22% ▲ +5.92% +6.34% vs SPY
  2. May 18, 202626w ago 6-K Neutral 4/10 Viewing Entry $5.17 to $4.70 Now $3.59 −30.56% ▼ −9.09% −10.67% vs SPY
  3. May 13, 202626w ago 6-K Neutral 2/10 Entry $5.35 to $4.54 Now $3.59 −32.90% ▼ −15.14% −14.53% vs SPY
Showing 3 of 3

US Market Status

Market Closed · Opens in 6h 1m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 18, 2026